Revah; Frederic

Patent Applications and Registrations

Patent applications and USPTO patent grants for Revah; Frederic.The latest application filed is for "use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders".

Company Profile

0.9.15

Revah; Frederic - Paris FR
Revah; Frederic - Antony FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders Grant 9,284,252 - Herzberg , et al. March 15, 2	2016-03-15
Use Of Jasmonate Ester Derivatives For Treating Benign Hyperproliferative Skin Disorders App 20150080430 - HERZBERG; Max ; et al.	2015-03-19
Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases Grant 8,431,119 - Mallet , et al. April 30, 2	2013-04-30
Use Of Jasmonate Ester Derivatives For Treating Benign Hyperproliferative Skin Disorders App 20120083529 - Herzberg; Max ; et al.	2012-04-05
Separation Method Of Biological Objects Relative To Their Viscoelastic Properties App 20100248207 - Raz; Ryan ; et al.	2010-09-30
Separation And Sorting Of Different Biological Objects App 20090170199 - RAZ; Ryan Stephen ; et al.	2009-07-02
Pharmaceutical Compositions And Utilization Thereof Particularly For The Treatment Of Neurodegenerative Diseases App 20080032284 - MALLET; Jacques ; et al.	2008-02-07
Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative disorders Grant 7,273,854 - Mallet , et al. September 25, 2	2007-09-25
Adenovirus comprising a gene coding for glutathione peroxidase Grant 7,241,591 - Barkats , et al. July 10, 2	2007-07-10
Use of alverine, alone or in combination with a tricyclic antidepressant or an antidepressant which is a specific inhibitor of serotonin reuptake for treatment of depression App 20060223891 - Migeon; Jacques ; et al.	2006-10-05
Adenovirus including a gene coding for a superoxide dismutase App 20050244381 - Mallet, Jacques ; et al.	2005-11-03
Recombinant adenoviruses encoding glial cell neurotrophic factor (GDNF) App 20050069523 - Horellou, Philippe ; et al.	2005-03-31
Utilization of alverine, alone or in combination with tricyclic antidepressant or a specific serotonin reuptake inhibitor for the treatment of depression App 20050065218 - Migeon, Jacques ; et al.	2005-03-24
Adenovirus comprising a gene coding for glutathione peroxidase App 20040175363 - Barkats, Martine ; et al.	2004-09-09
Method for treating amyotrophic lateral sclerosis Grant 6,723,315 - Mallet , et al. April 20, 2	2004-04-20
Recombinant adenoviruses coding for basic fibroblast growth factors (BFGF) Grant 6,685,934 - Mallet , et al. February 3, 2	2004-02-03
Adenoviral-vector-mediated gene transfer into medullary motor neurons Grant 6,632,427 - Finiels , et al. October 14, 2	2003-10-14
Muscle reinnervation and motor axon sprouting by administering DNA sequences encoding NT-3 and CNTF Grant 6,552,003 - Finiels , et al. April 22, 2	2003-04-22
Adenovirus Including A Gene Coding For A Superoxide Dismutase App 20030059455 - BARKATS, MARTINE ; et al.	2003-03-27
Adenoviral-vector-mediated Gene Transfer Into Medullary Motor Neurons App 20020164303 - FINIELS, FRANCOISE ; et al.	2002-11-07
Method Of Stimulating Nerve Regeneration App 20020071828 - PEULVE, PASCAL ; et al.	2002-06-13
Recombinant Adenoviruses Coding For Glial-derived Cell Neurotrophic Factor (gdnf) App 20020031493 - HORELLOU, PHILIPPE ; et al.	2002-03-14
Adenovirus Comprising A Gene Coding For Glutathione Peroxidase App 20010029249 - BARKATS, MARTINE ; et al.	2001-10-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.